Inflammatory Biomarkers in Addictive Disorders
Substance use disorders are a group of diseases that are associated with social, professional, and family impairment and that represent a high socio-economic impact on the health systems of countries around the world. These disorders present a very complex diagnosis and treatment regimen due to the...
Main Authors: | Alvaro Morcuende, Francisco Navarrete, Elena Nieto, Jorge Manzanares, Teresa Femenía |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/12/1824 |
Similar Items
-
Exploring the Role of DARPP-32 in Addiction: A Review of the Current Limitations of Addiction Treatment Pathways and the Role of DARPP-32 to Improve Them
by: Megan R. Greener, et al.
Published: (2022-08-01) -
Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders
by: Alvaro Morcuende, et al.
Published: (2022-04-01) -
Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
by: María Salud García-Gutiérrez, et al.
Published: (2022-05-01) -
Biomarkers of the Endocannabinoid System in Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2022-03-01) -
Identification and Characterization of Biomarkers and Their Role in Opioid Addiction by Integrated Bioinformatics Analysis
by: Xiuning Zhang, et al.
Published: (2020-11-01)